VACCINEX, INC.

Rochester, NY · CIK 0001205922 · Biotech · Public

Monoclonal antibody therapeutic targeting Semaphorin 4D for Alzheimer's Disease and cancer, plus antibody discovery platform (ActivMab) for transmembrane antigen presentation

vaccinex.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$44M
10 Form D · Sep 2024
24 months since last filing
Contracts
—
No federal contracts on record
Patents
40
30 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$6,000,000
Private capital raisedForm D · SEC$13,799,915
Private capital raisedForm D · SEC$7,474,986
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$8,000,000
Private capital raisedForm D · SEC$2,000,000
Private capital raised· 1 of 3 same dayForm D · SEC$1,474,520
Private capital raised· 2 of 3 same dayForm D · SEC$1,750,000
Private capital raised· 3 of 3 same dayForm D · SEC$1,240,737
Private capital raisedForm D · SEC$200,155
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2913GENSAIC, INC.——
2914TRUCODE GENE REPAIR, INC.——
2915Sermonix Pharmaceuticals, Inc.—$43M
2916VACCINEX, INC.—$44M
2917STELLATE DNA LLC——
2918Propeller Bio——
2919EICOSIS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 24 related persons
  • Chrystyna Bedrij StecykDirector
  • Alejandro BerlinDirector
  • Steven CobournExecutive Officer
  • Alan CraneDirector
  • Elizabeth EvansExecutive Officer
  • Jacob FriebergDirector
  • Albert FriedbergDirector
  • J. GoaterDirector
  • J. Jeffrey GoaterDirector
  • John LeonardExecutive Officer
  • Bala ManianDirector
  • Bala Manian Ph.D.Director
  • Bala Manian, Ph.D.Director
  • Scott RoyerExecutive Officer
  • Jill SanchezExecutive Officer
  • Ernest SmithExecutive Officer
  • Ernest Smith Ph.D.Executive Officer
  • Ernest Smith, Ph.D.Executive Officer
  • Gerald Van StrydonckDirector
  • Raymond WatkinsExecutive Officer
  • Barbara YanniDirector
  • Barbara YannniDirector
  • Maurice ZaudererDirector · Executive Officer
  • Maurice Zauderer, Ph.D.Director · Executive Officer

Patents

USPTO · 30 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.